H.R.4400 - Advancing Education on Biosimilars Act of 2019116th Congress (2019-2020)
|Sponsor:||Rep. Bucshon, Larry [R-IN-8] (Introduced 09/19/2019)|
|Committees:||House - Energy and Commerce; Ways and Means|
|Latest Action:||House - 09/20/2019 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.4400 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in House (09/19/2019)
Advancing Education on Biosimilars Act of 2019
This bill requires the Department of Health and Human Services (HHS) to maintain a website and undertake other activities to educate health care providers, patients, and caregivers about biological products, biosimilar biological products, and interchangeable biosimilar biological products.
Among other activities, HHS must develop or improve continuing education programs that address clinical considerations for biological and related products. Health care providers eligible for the Merit-based Incentive Payment System in Medicare may count completion of such a program as a clinical practice improvement activity.